2021
Pancreatic Neuroendocrine Tumors
Muniraj T, Aslanian H. Pancreatic Neuroendocrine Tumors. 2021, 1933-1951. DOI: 10.1007/978-3-030-30192-7_81.Peer-Reviewed Original ResearchNeuroendocrine tumorsProlongs disease-free survivalDiagnosis of NETsNon-functioning neuroendocrine tumoursDisease-free survivalCareful clinical historyTreatment of choicePancreatic neuroendocrine tumorsQuality of lifeHormone hypersecretionMetastatic diseaseNonfunctional tumorsSurgical resectionTreatment modalitiesClinical historyPotential treatmentHeterogeneous groupTumorsMass effectAgeTreatmentLaboratory testsHypersecretionResectionPatients
2020
Pancreatic Neuroendocrine Tumors
Muniraj T, Aslanian H. Pancreatic Neuroendocrine Tumors. 2020, 1-19. DOI: 10.1007/978-3-319-90761-1_81-1.Peer-Reviewed Original ResearchNeuroendocrine tumorsProlongs disease-free survivalDiagnosis of NETsNon-functioning neuroendocrine tumoursDisease-free survivalCareful clinical historyTreatment of choicePancreatic neuroendocrine tumorsQuality of lifeHormone hypersecretionMetastatic diseaseNonfunctional tumorsSurgical resectionTreatment modalitiesClinical historyPotential treatmentHeterogeneous groupTumorsMass effectAgeTreatmentLaboratory testsHypersecretionResectionPatients
2015
The Clinical Utility of a Novel Blood-Based Multi-Transcriptome Assay for the Diagnosis of Neuroendocrine Tumors of the Gastrointestinal Tract
Modlin I, Kidd M, Bodei L, Drozdov I, Aslanian H. The Clinical Utility of a Novel Blood-Based Multi-Transcriptome Assay for the Diagnosis of Neuroendocrine Tumors of the Gastrointestinal Tract. The American Journal Of Gastroenterology 2015, 110: 1223. PMID: 26032155, DOI: 10.1038/ajg.2015.160.Peer-Reviewed Original ResearchConceptsPancreatic neuroendocrine tumorsNeuroendocrine tumorsCgA measurementMalignant gastrointestinal diseasesBlood-based biomarkersNeuroendocrine tumor diseaseExtensive diseaseIntestinal carcinoidsColorectal cancerGastrointestinal diseasesCgA levelsPancreatic diseaseClinical utilityGastrointestinal tractDiagnostic strategiesNETestDiseaseTumorsNETest scoreTumor diseaseNovel bloodNational InstituteDiagnosisBiomarkersCgA
2014
324 A Multi-Transcript Blood Signature Outperforms Chromogranin a for Detecting Gut Neuroendocrine Tumors
Modlin I, Kidd M, Drozdov I, Alaimo D, Callahan S, Teixeira N, Aslanian H, Bodei L. 324 A Multi-Transcript Blood Signature Outperforms Chromogranin a for Detecting Gut Neuroendocrine Tumors. Gastroenterology 2014, 146: s-73. DOI: 10.1016/s0016-5085(14)60265-1.Peer-Reviewed Original Research
2013
Mo1542 Endosonographic and Cyst Fluid Characteristics of Cystic Pancreatic Neuroendocrine Tumors: a Multicenter Case Series
Ho H, Eloubeidi M, Siddiqui U, Brugge W, Rossi F, Casey B, Aslanian H. Mo1542 Endosonographic and Cyst Fluid Characteristics of Cystic Pancreatic Neuroendocrine Tumors: a Multicenter Case Series. Gastrointestinal Endoscopy 2013, 77: ab420. DOI: 10.1016/j.gie.2013.03.290.Peer-Reviewed Original Research